CUAMC
SGMT icon

China Universal Asset Management Company’s Sagimet Biosciences SGMT Stock Holding History

China Universal Asset Management Company’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.3K Buy
9,738
+4,237
+77% +$28.8K ﹤0.01% 438
2026
Q1 		$28.7K Buy
5,501
+449
+9% +$2.5K ﹤0.01% 483
2025
Q4 		$29.9K Buy
+5,052
New +$36.3K ﹤0.01% 477

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

China Universal Asset Management Company's SGMT Position: Q2 2026 in Review

China Universal Asset Management Company increased its Sagimet Biosciences (SGMT) stake by 77% in Q2 2026, buying an estimated $28.8K and bringing the position to 9,738 shares worth $75.3K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

China Universal Asset Management Company first reported a position in SGMT in Q4 2025 and has held it in 3 quarters since. 50 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • China Universal Asset Management Company held 9,738 shares of Sagimet Biosciences worth $75.3K as of Q2 2026.
  • China Universal Asset Management Company bought 4,237 Sagimet Biosciences shares in Q2 2026, an estimated $28.8K.
  • Sagimet Biosciences made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #438 holding.
  • China Universal Asset Management Company first reported a position in Sagimet Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 50 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.